The Association for Diagnostics & Laboratory Medicine (ADLM) Continuing Medical Education (CME) program advances the organization’s mission of Better Health for All through Laboratory Medicine by enhancing physicians’ knowledge, competence, and performance in clinical laboratory medicine and diagnostics. Operating within ADLM’s strategic and quality improvement framework, the CME program provides high-quality, independent educational activities that strengthen physicians’ ability to effectively utilize, perform, and interpret laboratory testing in the delivery of patient care. Through these efforts, ADLM supports physicians in translating diagnostic innovation into improved decision-making and outcomes across the healthcare continuum.
Purpose
The purpose of ADLM’s CME program is to serve as a trusted and premier provider of education in clinical laboratory medicine. The program aims to improve healthcare by equipping physicians, clinical pathologists, and other medical specialists with the knowledge and practical skills necessary for the appropriate use, performance, and interpretation of laboratory tests, thereby enhancing clinical effectiveness and patient management.
Content Areas
ADLM’s CME activities address key areas of clinical laboratory medicine and diagnostics, including scientific and technical knowledge, test selection and interpretation, clinical effectiveness, laboratory automation, data science and informatics, quality management, clinical consultation, and leadership in multidisciplinary healthcare teams. Educational content reflects current and emerging needs in the field, identified through ongoing evaluation, stakeholder input, and alignment with ADLM’s 2025–2029 Strategic Plan.
Target Audience
The primary audience for ADLM’s CME activities includes physicians specializing in laboratory medicine and clinical pathology. Selected programs also serve other physicians whose practice involves diagnostic testing, such as internists, pediatricians, and subspecialists, as well as healthcare professionals engaged in collaborative laboratory-based decision-making.
Expected Results
ADLM’s CME program is designed to improve learner knowledge, competence, and performance, thereby contributing to higher-quality diagnostic care and more effective clinical decision-making.
Specifically, the program expects to:
- Increase knowledge of current and emerging advances in clinical laboratory diagnostics, biomarker discovery, and applied laboratory medicine.
- Enhance competence by equipping learners with strategies to address diagnostic and therapeutic challenges, improve test selection and interpretation, and apply advances in laboratory automation, informatics, and team-based care.
- Improve performance by fostering behavior change and application of new knowledge in clinical and laboratory practice, contributing to measurable improvements in diagnostic accuracy and patient management.
In alignment with ADLM’s strategic priorities, the CME program continuously evaluates outcomes to ensure activities remain responsive to evolving learner needs, advances in diagnostic science, and the growing integration of laboratory medicine into precision healthcare.
Through these efforts, ADLM aims to be a premier provider of CME in laboratory medicine and to meaningfully contribute to the improvement of patient care for all.
CME Subcommittee
The CME Subcommittee is responsible for overseeing ADLM’s CME accreditation program. The members and their financial disclosures are below. All disclosures are reviewed and mitigated on an ongoing basis.
Clayton Wilburn, MD, DABCC
Associate Professor
University of Vermont Medical Center
Disclosures: None
Baha Adam, MD, MSc, PhD, DABCC
Professor
Xavier University of Louisiana
Disclosures: None
Berna Aslan, MD, MSc, DABCC, FADLM, FCACB
Clinical Biochemist; Director, Massachusetts Spectrometry Lab and Postdoctoral Training Program in Clinical Biochemistry
NL Health Services
Disclosures: None
Melissa Ulas, MD, PhD
Medical Director, Assistant Professor, Associate Director of Chemistry and POCT
Temple University Health System
Disclosures:
- Honoraria/Expenses: Sysmex America
- Consulting Fees: Accurant Biotech Inc., siParadigm Diagnostics LLC
William Winter, MD, DABCC, FADLM, FCAP
Professor (Retired)
University of Florida
Disclosures:
- Consulting Fees: Bio-Rad
- Stocks/Bonds: Eli Lilly, Johnson & Johnson, Merck, Pfizer